The estimated Net Worth of Paul Alloway is at least $72.3 Thousand dollars as of 25 March 2024. Dr Alloway owns over 23,530 units of Homology Medicines Inc stock worth over $47,956 and over the last 2 years he sold FIXX stock worth over $24,344.
Dr has made over 6 trades of the Homology Medicines Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 23,530 units of FIXX stock worth $21,883 on 25 March 2024.
The largest trade he's ever made was exercising 23,530 units of Homology Medicines Inc stock on 25 March 2024 worth over $21,883. On average, Dr trades about 10,435 units every 64 days since 2023. As of 25 March 2024 he still owns at least 51,566 units of Homology Medicines Inc stock.
You can see the complete history of Dr Alloway stock trades at the bottom of the page.
Dr. Paul Alloway J.D., Ph.D. is the Chief Legal Officer & Sec. at Homology Medicines Inc.
Dr D is 50, he's been the Chief Legal Officer & Sec. of Homology Medicines Inc since . There are 16 older and 2 younger executives at Homology Medicines Inc. The oldest executive at Homology Medicines Inc is Steven Gillis, 67, who is the Independent Director.
Paul's mailing address filed with the SEC is C/O HOMOLOGY MEDICINES, INC., ONE PATRIOTS PARK, BEDFORD, MA, 01730.
Over the last 7 years, insiders at Homology Medicines Inc have traded over $108,214,465 worth of Homology Medicines Inc stock and bought 3,033,333 units worth $51,999,993 . The most active insiders traders include Steven Gillis, James Edeerfield Management..., and Kush Parmar. On average, Homology Medicines Inc executives and independent directors trade stock every 26 days with the average trade being worth of $106,785. The most recent stock trade was executed by Paul Alloway on 25 March 2024, trading 23,530 units of FIXX stock currently worth $21,883.
homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
Homology Medicines Inc executives and other stock owners filed with the SEC include: